Trial Profile
A Study to Assess the Effectiveness of Teriparatide (FORTEO) for Increasing Bone Mass and Improving Bone Strength in Adults Affected With Osteogenesis Imperfecta (OI)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteogenesis imperfecta
- Focus Therapeutic Use
- 28 Sep 2015 New trial record